Last $76.25 USD
Change Today +1.52 / 2.03%
Volume 3.2M
DHR On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 8:04 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

2200 Pennsylvania Avenue NW

Suite 800W

Washington, DC 20037

United States

Phone: 202-828-0850

Fax: 202-828-0860

al tools that are used by scientists to study cells and cell components to gain an understanding of biological matters. Pharmaceutical and biotechnology companies, universities, medical schools, and research institutions use these tools to study the causes of disease, identify new therapies, and test new drugs and vaccines. Diagnostics The diagnostics business consists of the company’s clinical laboratory (or clinical lab), acute care, and pathology diagnostics businesses. The company’s clinical lab business is a primary manufacturer and marketer of biomedical testing instrument systems, tests, and supplies that are used to evaluate and analyze samples made up of body fluids, cells, and other substances. The information generated is used to diagnose disease, monitor and guide treatment and therapy, assist in managing chronic disease, and assess patient status in hospital, outpatient, and physician's office settings. The business offers the following products: The company’s chemistry systems use electrochemical detection and chemical reactions with patient samples to detect and quantify substances of diagnostic interest in blood, urine, and other body fluids. Commonly performed tests include glucose, cholesterol, triglycerides, electrolytes, proteins, and enzymes, as well as tests to detect urinary tract infections, and kidney and bladder disease. The company’s immunoassay systems also detect and quantify chemical substances of diagnostic interest in body fluids, primarily in circumstances where specialized diagnosis is required. Commonly performed immunoassay tests assess thyroid function, screen and monitor for cancer and cardiac risk, and provide information in fertility and reproductive testing. The company’s cellular analysis business includes hematology and flow cytometry products. The business’ hematology systems use principles of physics, optics, electronics, and chemistry to separate cells of diagnostic interest and then quantify and characterize them, allowing clinicians to study formed elements in blood (such as red and white blood cells and platelets). The business’ flow cytometry products sort, identify, categorize, and characterize various types of cells in suspension, allowing clinicians to determine cell types and characteristics, and analyze specific cell populations based on molecular differences. The business also offers genome profiling services. The company also offers systems and workflow solutions that allow laboratories to automate various steps from the pre-analytical through post-analytical stages, including sample barcoding/information tracking, centrifugation, aliquotting, storage, and conveyance. These systems along with the analyzers are controlled through laboratory level software that enables laboratory managers to monitor samples, results, and lab efficiency. Typical users of this business’ clinical lab products include hospitals, physician’s offices, veterinary laboratories, reference laboratories, and pharmaceutical clinical trial laboratories. The acute care diagnostics business is a provider of instruments, software and related consumables and services that are used in both laboratory and point-of-care environments to measure critical parameters, including blood gases, electrolytes, metabolites and cardiac markers, as well as for anemia and high-sensitivity glucose testing. Typical users of these products include hospital central laboratories, intensive care units, hospital operating rooms, hospital emergency rooms, physician’s office laboratories and blood banks. The company’s pathology diagnostics business is a histology company in the anatomical pathology market, offering a suite of instrumentation and related consumables used across the entire workflow of a pathology laboratory. Its pathology diagnostics products include tissue embedding, processing, and slicing (microtomes) instruments and related reagents and consumables; chemical and immuno-staining instruments, reagents, antibodies, and consumables; slide coverslipping and slide/cassette marking instruments; and imaging instrumentation, including slide scanners, microscopes, cameras, and software so

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DHR:US $76.25 USD +1.52

DHR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.39 USD +0.93
Emerson Electric Co $62.96 USD +1.73
Kimberly-Clark Corp $111.23 USD +3.19
Schneider Electric SE €57.32 EUR -0.31
Thermo Fisher Scientific Inc $118.22 USD +3.89
View Industry Companies
 

Industry Analysis

DHR

Industry Average

Valuation DHR Industry Range
Price/Earnings 19.6x
Price/Sales 2.7x
Price/Book 2.2x
Price/Cash Flow 19.3x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DANAHER CORP, please visit www.danaher.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.